Literature DB >> 23685279

Neuroendocrine tumours--challenges in the diagnosis and classification of pulmonary neuroendocrine tumours.

M A den Bakker1, F B J M Thunnissen.   

Abstract

Pulmonary neuroendocrine (NE) proliferations are a diverse group of disorders which share distinct cytological, architectural and biosynthetic features. Tumours composed of NE cells are dispersed among different tumour categories in the WHO classification of tumours and as such do not conform to a singular group with regards to treatment and prognosis. This is reflected by the highly variable behaviour of NE proliferations, ranging from asymptomatic, for instance in diffuse idiopathic pulmonary NE cell hyperplasia and tumourlets, to highly malignant cancers such as small cell lung cancer and large cell NE carcinoma. In this review NE proliferations are described as distinct entities ranging from low grade lesions to high grade cancers. The differential diagnoses are considered with each of the entries. Finally, mention is made of tumours which may show some NE features.

Entities:  

Keywords:  HISTOPATHOLOGY; LUNG; Neuroendocrine

Mesh:

Year:  2013        PMID: 23685279     DOI: 10.1136/jclinpath-2012-201310

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Biology and evolution of poorly differentiated neuroendocrine tumors.

Authors:  David S Rickman; Himisha Beltran; Francesca Demichelis; Mark A Rubin
Journal:  Nat Med       Date:  2017-06-06       Impact factor: 53.440

2.  Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Mauro Papotti; Luisella Righi; Gaia Gatti; Patrick Maisonneuve; Barbara Valeri; Ugo Pastorino; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-01-04       Impact factor: 4.064

Review 3.  Update on large cell neuroendocrine carcinoma.

Authors:  Kenzo Hiroshima; Mari Mino-Kenudson
Journal:  Transl Lung Cancer Res       Date:  2017-10

Review 4.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

5.  Primary paraganglioma of the lung: a case report.

Authors:  Giuseppe Fiorentino; Anna Annunziata; Nicolina De Rosa
Journal:  J Med Case Rep       Date:  2015-09-02

6.  Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.

Authors:  Giuseppe Pelosi; Fabrizio Bianchi; Elisa Dama; Michele Simbolo; Andrea Mafficini; Angelica Sonzogni; Sara Pilotto; Sergio Harari; Mauro Papotti; Marco Volante; Gabriella Fontanini; Luca Mastracci; Adriana Albini; Emilio Bria; Fiorella Calabrese; Aldo Scarpa
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

Review 7.  Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis.

Authors:  Marina K Baine; Natasha Rekhtman
Journal:  Transl Lung Cancer Res       Date:  2020-06

8.  Diffuse Neuroendocrine Cell Hyperplasia: Report of Two Cases.

Authors:  Cevriye Cansız Ersöz; Ayten Kayı Cangır; Serpil Dizbay Sak
Journal:  Case Rep Pathol       Date:  2016-05-17

9.  Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation.

Authors:  Sara Lázaro; Miriam Pérez-Crespo; Ana Belén Enguita; Pilar Hernández; Jesús Martínez-Palacio; Marta Oteo; Julien Sage; Jesús M Paramio; Mirentxu Santos
Journal:  Oncotarget       Date:  2017-01-17

10.  Management and Follow-up of Patients with a Bronchial Neuroendocrine Tumor in the Last Twenty Years in Ireland: Expected Inconsistencies and Unexpected Discoveries.

Authors:  Asta Agasarova; Clare Harnett; Niall Mulligan; Muhammad Shakeel Majeed; Alberto Caimo; Gianluca Tamagno
Journal:  Int J Endocrinol       Date:  2018-08-29       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.